Polar Capital Global Healthcare Trust focuses on fast-growing healthcare firms seeking to shake up the traditional medical market
WHAT DOES IT DO? It focuses on fast-growing healthcare firms seeking to shake up the traditional medical market.
It aims to find firms which can offer the Holy Grail of better healthcare for less money.
The trust is due to wind up in 2025, selling all its holdings and paying the cash to investors.
WHAT DOES THE MANAGER INVEST IN? Run by Dan Mahony, Gareth Powell and James Douglas, Polar Capital puts 90 per cent of its cash in ‘growth’ stocks and the rest into ‘innovation’.
Growth firms are worth at least £3.9 billion but still expanding. Innovation stocks are smaller firms with the potential to surge in value. Top holdings include US medical device firm Medtronic and drug maker Merck.
WHAT DO EXPERTS LIKE? Sam Slator, of Chelsea Financial Services, says that the trust’s managers previously worked in healthcare as research scientists.
He says: ‘This trust could really capture the growth opportunities in the sector.’
ANY DOWNSIDES? Finding small healthcare firms which can really take off is notoriously difficult and the industry has a high failure rate – so investors should be prepared for some of the fund’s bets to take a share price tumble.